| Appl No |
TE Code |
RLD |
Active Ingredient |
Dosage Form- Route |
Strength |
Proprietary Name |
| 007569 |
AN |
No |
Albuterol Sulfate |
Solution: Inhalation |
EQ 0.083% Base |
Albuterol Sulfate |
| 075464 |
AB1 |
No |
Fluoxentine Hydrochloride |
Capsule: Oral |
EQ 10 MG Base |
Fluoxentine Hydrochloride |
| 075464 |
AB1 |
No |
Fluoxentine Hydrochloride |
Capsule: Oral |
EQ 20 MG Base |
Fluoxentine Hydrochloride |
| 077072 |
AN |
No |
Ipratropium Bromide |
Solution: Inhalation |
0.02% |
Ipratropium Bromide |
Landela Pharmaceutical (formerly known as RxElite, Inc.) is currently developing several products in the niche pharmaceutical area not listed in the previous table. Landela has current development deals with multi-dose opthalmics and is exploring partnerships in injectibles, otic, inhalation, and other niche based products.
Landela is currently looking for opportunities to license in additional products, develop new products or license various approved products to companies that would like to sell, distribute or contract manufacture these products in the U.S.
Please contact Landela if you would like to discuss partnership or license opportunities.
|
|
